Department of Psychiatry, Columbia University and the New York State Psychiatric Institute, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA.
Drug Alcohol Depend. 2010 Jun 1;109(1-3):130-8. doi: 10.1016/j.drugalcdep.2009.12.018. Epub 2010 Jan 15.
The relationship between pain and prescription opioid abuse is poorly understood. Determining whether a patient is seeking additional opioid medications in order to alleviate pain or to abuse the drugs can be difficult. The present study was designed to evaluate two variables that may influence the abuse liability of opioids: drug use history and the presence or absence of experimentally induced pain. Eighteen healthy participants completed this outpatient study. One group was abusing prescription opioids (N=9) and one group had used prescription opioids medically but did not abuse them (N=9). All participants completed twelve sessions during which the effects of orally delivered oxycodone (0, 15, 30mg/70kg, PO) were examined. One dose was tested per day under double-blind conditions and sessions were separated by at least 48h. During the first "sample" session each week, participants were given $10 and the dose that was available later that week. During the second "choice" session, participants could self-administer either money or the previously sampled dose. Six sessions involved repeated hand immersions in cold water (4 degrees C) and six sessions involved immersions in warm water (37 degrees C). Most of the positive subjective effects of oxycodone were similar between the groups, but oxycodone self-administration significantly differed between groups. Non-abusers self-administered active doses of oxycodone only when they were in pain while abusers self-administered oxycodone regardless of the pain condition. These data suggest that an assessment of the reinforcing effects of opioids may be a sensitive method for differentiating opioid abusers from non-abusers.
疼痛与处方类阿片类药物滥用之间的关系尚未得到充分理解。确定患者是否寻求额外的阿片类药物来缓解疼痛或滥用这些药物可能具有一定难度。本研究旨在评估两个可能影响阿片类药物滥用倾向的变量:药物使用史和是否存在实验性疼痛。18 名健康参与者完成了这项门诊研究。一组是滥用处方类阿片类药物者(N=9),另一组是曾因医疗需要使用过处方类阿片类药物但没有滥用的人(N=9)。所有参与者都完成了 12 次口服给予羟考酮(0、15、30mg/70kg,PO)的测试。每天以双盲条件测试一种剂量,且各次测试之间至少间隔 48 小时。在每周的第一次“采样”测试中,每位参与者都获得 10 美元和下周可用的剂量。在第二次“选择”测试中,参与者可以自行选择钱或之前采样的剂量。6 次测试涉及反复将手浸入 4°C 的冷水中,6 次测试涉及将手浸入 37°C 的温水中。羟考酮的大部分阳性主观效应在两组之间相似,但羟考酮的自我给药在两组之间存在显著差异。非滥用者仅在疼痛时才自我给予羟考酮的活性剂量,而滥用者无论疼痛状况如何都会自我给予羟考酮。这些数据表明,评估阿片类药物的强化效应可能是区分阿片类药物滥用者和非滥用者的敏感方法。